- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00895154
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
23 de abril de 2019 atualizado por: Allison King, Washington University School of Medicine
The overall goal of this project is to determine the feasibility of conducting a cognitive intervention for children with sickle cell disease.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
The primary aims of this clinical trial are:
- Determine the effectiveness of targeted learning and memory strategy remediation in students with sickle cell disease and cognitive deficits.
- Determine if there is improvement in academic achievement after targeted memory strategy remediation.
Tipo de estudo
Intervencional
Inscrição (Real)
21
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Missouri
-
Saint Louis, Missouri, Estados Unidos, 63110
- Washington University School of Medicine/St. Louis Children's Hospital
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
8 anos a 18 anos (Filho, Adulto)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Sickle cell disease that is confirmed by hemoglobin analysis
- Has a brain magnetic resonance imaging (MRI) document reading by a neuroradiologist
- Cognitive deficits, which are defined by one standard deviation lower than the normal ranges of an age-based standard score in cognitive tests that are evaluated by a psychologist
- Must be a student who will remain in school for at least 2 years
- Must provide informed consent with assent in accordance with the institutional policies (institutional review board approval)
Exclusion Criteria:
- Known developmental delays (these participants are ineligible because their learning potential may be biased from a prior insult)
- Intelligent quotient is less than 50 (may have impaired learning potential)
- Aphasic (i.e., unable to produce intelligible speech)
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: General Tutoring Group
Participants will receive general tutoring in the subject of his/her choice.
|
Participants will be tutored for approximately 8-10 hours per month during the school year.
|
|
Experimental: Tutoring + Memory Training Group
Participants will receive tutoring and memory training.
|
Participants will be tutored for approximately 8-10 hours per month during the school year.
Participants will receive memory training for approximately 8-10 hours per month during the school year.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Full Scale IQ (FSIQ) (WASI)
Prazo: After >/= 50 hours of tutoring
|
The WASI is a brief, reliable measure of intelligence.
Participants engage in 4 subtests: Block Design, Vocabulary, Similarities, and Matrix Reasoning.
Participants receive a raw score on each of these 4 subtests.
This raw score is converted to a T score using a score chart in the WASI manual.
The T scores from all 4 subtests are summed together to obtain a Full Scale Sum of T Scores.
This Full Scale Sum of T Scores is converted to a Full Scale IQ-4 Composite Score using a score chart published in the WASI manual.
Higher scores indicate better intelligence.
FSIQ-4 Range: 40-160.
Average FSIQ-4 =100, standard deviation is +/- 15.
|
After >/= 50 hours of tutoring
|
|
Verbal IQ (PIQ) (WASI)
Prazo: After >/= 50 hours of tutoring
|
The VIQ score is comprised from the Vocabulary and Similarities subtests of the WASI-4.
The raw scores from these subtests are converted to T scores using score charts in the manual.
The T scores are summed together for a Verbal Sum of T Scores.
This score is converted to a Composite VIQ score using a score chart in the manual.
Higher scores = better Verbal IQ.
Range = 45-160.
Average = 100; standard deviation +/- 15.
|
After >/= 50 hours of tutoring
|
|
Performance IQ (PIQ) (WASI)
Prazo: After >/= 50 hours of tutoring
|
The PIQ score is comprised from the Matrix Reasoning and Block Design subtests of the WASI-4.
The raw scores from these subtests are converted to T scores using score charts in the manual.
The T scores are summed together for a Performance Sum of T Scores.
This score is converted to a Composite PIQ score using a score chart in the manual.
Higher scores = better Performance IQ.
Range = 45-160.
Average = 100; standard deviation +/- 15.
|
After >/= 50 hours of tutoring
|
|
Letter Word Identification T Score (WJ-III)
Prazo: After >/= 50 hours of tutoring
|
This sub-test measures a student's word identification skills.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Reading Fluency T Score (WJ-III)
Prazo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to read simple sentences quickly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Calculations T Score (WJ-III)
Prazo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to perform paper and pencil math computations.A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Math Fluency T Score (WJ-III)
Prazo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to solve simple addition, subtraction and multiplication facts quickly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
Spelling T Score (WJ-III)
Prazo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to write orally presented words correctly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
|
California Verbal Learning Test-Children's Version (CVLT-C) List A Trials 1-5 Immediate Recall T Score
Prazo: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
CVLT-C Trials 1-5 Semantic Clustering T Score
Prazo: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The CVLT-C consists of five learning trials of 15 words which can be organized into three semantic categories.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
CVLT-C Trials 1-5 Short Delay Recall T Score
Prazo: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
CVLT-C Trials 1-5 Long Delay Recall T Score
Prazo: T scores were obtained at baseline and again at follow-up (after partcipant completed 50 hours of tutoring)
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
T scores were obtained at baseline and again at follow-up (after partcipant completed 50 hours of tutoring)
|
|
CVLT-C Trials 1-5 Recognition Discriminability T Score
Prazo: After >/= 50 hours of tutoring
|
TThe CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
|
Delis Kaplan Executive Function System (D-KEFS) Number/Letter Switching T Score
Prazo: After >/= 50 hours of tutoring
|
The D-KEFS allows for the assessment of executive functions.
There are 9 stand alone tests that can be individually or group administered.
The Number-Letter Switching condition of the Trails Making sub-test specifically assesses flexibility of thinking on a visual-motor sequencing task.
A participant's raw score (# of items answered correctly) is converted to a T score using tables provided in the manual.
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Allison King, MD, MPH, Washington University School of Medicine
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Publicações Gerais
- Yerys BE, White DA, Salorio CF, McKinstry R, Moinuddin A, DeBaun M. Memory strategy training in children with cerebral infarcts related to sickle cell disease. J Pediatr Hematol Oncol. 2003 Jun;25(6):495-8. doi: 10.1097/00043426-200306000-00014.
- King AA, White DA, McKinstry RC, Noetzel M, Debaun MR. A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes. Neurology. 2007 Jun 5;68(23):2008-11. doi: 10.1212/01.wnl.0000264421.24415.16.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de setembro de 2003
Conclusão Primária (Real)
1 de julho de 2014
Conclusão do estudo (Real)
1 de dezembro de 2014
Datas de inscrição no estudo
Enviado pela primeira vez
6 de maio de 2009
Enviado pela primeira vez que atendeu aos critérios de CQ
6 de maio de 2009
Primeira postagem (Estimativa)
8 de maio de 2009
Atualizações de registro de estudo
Última Atualização Postada (Real)
15 de maio de 2019
Última atualização enviada que atendeu aos critérios de controle de qualidade
23 de abril de 2019
Última verificação
1 de abril de 2019
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 653
- K23HL079073 (Concessão/Contrato do NIH dos EUA)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Anemia falciforme
-
Xuzhou Central HospitalConcluídoInfarto Agudo do Miocárdio (IAM) | Principais Eventos Adversos Cardiovasculares | Red Blood Cell Distribution Width-to-albumin RatioChina
-
Kyowa Kirin, Inc.Ainda não está recrutandoT-Cell NHL (PTCL ou CTCL)Estados Unidos, Itália, Espanha
-
Taichung Veterans General HospitalConcluídoCardiotoxicidade | Carcinoma de Pulmão de Células não Pequenas (Termo MeSH: Carcinoma, Non-Small-Cell Lung) | Efeitos Secundários e Reações Adversas Relacionadas com Medicamentos (Termo MeSH) | Inibidor da Tirosina Quinase do EgfrTaiwan
-
Fondazione del Piemonte per l'OncologiaRecrutamentoCâncer de mama | Cancro do ovário | Câncer colorretal | Melanoma (câncer de pele) | Carcinoma de Pulmão de Células não Pequenas (Termo MeSH: Carcinoma, Non-Small-Cell Lung)Itália
-
Novartis PharmaceuticalsRescindidoMelanoma | Avançado EGFR mutante non Small Cell LungCancer (NSCLC) | KRAS G12-MUTANT NSCLC | Câncer de células escamosas esofágicas (SCC) | Cabeça/pescoço SCC | Tumores estromais gastrointestinais avançados (GIST) | NRAS/Braft WT avançado melanoma cutâneoEstados Unidos, Taiwan, Holanda, Canadá, Espanha, Cingapura, Itália, Japão, Coréia do Sul
Ensaios clínicos em General Tutoring
-
Hospital Civil de GuadalajaraRecrutamentoSíndrome da insuficiência respiratória agudaMéxico
-
Montefiore Medical CenterRetiradoInsuficiência cardíaca | Insuficiência Cardíaca Aguda Descompensada
-
Consorci d'Atenció Primària de Salut de l'EixampleConcluídoHipertensão | Aneurisma da aorta abdominal | AteromatoseEspanha
-
Consorci d'Atenció Primària de Salut de l'EixampleMedtronicConcluídoAneurisma da aorta abdominalEspanha
-
Hamilton Health Sciences CorporationConcluído
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...Bakirkoy Dr. Sadi Konuk Research and Training HospitalConcluídoAVC Isquêmico AgudoTurquia (Türkiye)
-
University of GaziantepConcluídoDor pós-operatória | Fratura de quadrilTurquia (Türkiye)
-
Region SkaneConcluído
-
King Fahad Medical CityDesconhecidoMudanças de temperatura corporal | Duração da estadia | Pré-Período | Transição | Alta do paciente
-
Hitit UniversityRecrutamentoNeoplasias Urológicas | Hiperplasia Prostática Benigna | AnestesiaTurquia (Türkiye)